Health and wellness influencer Janelle Rohner is receiving backlash after revealing that she’s been taking medication for ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Shares of WW International, formerly known as Weight Watchers, more than doubled after the company received a letter from an activist investor arguing against a Chapter 11 bankruptcy filing. The ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...

College of Charleston's Kindred Hurtado examines one woman's weight-loss journey with the assistance of semaglutides.